Thursday, December 19, 2024

Meta wins

The ideas and innovators shaping health care
Dec 19, 2024 View in browser
 
POLITICO Future Pulse Newsletter Header

By Ruth Reader and Erin Schumaker

POLICY PUZZLE

House Speaker Mike Johnson (R-La.).

House Speaker Mike Johnson (R-La.) has promised to address kids’ online safety in the new term. | Francis Chung/POLITICO

Meta has staved off legislation that would have forced it to make its platform safer for kids — for now. Advocates say the bipartisan bill’s death is a loss for youth mental health.

This year, the Kids Online Safety Act, a bill that would have required social media companies to remove product features doctors say harm kids’ health, passed in the Senate. But it couldn’t move in the House.

The bill’s backers, Sens. Marsha Blackburn (R-Tenn.) and Richard Blumenthal (D-Conn.), redrafted the bill multiple times to ensure it didn’t violate the First Amendment and persuaded free-speech enthusiast Elon Musk to support it. Still, House Speaker Mike Johnson refused to bring the bill to the floor, opting to take it up next year instead.

How did this happen? It’s possible that Johnson, who is now facing a government shutdown deadline, didn’t have the bandwidth to deal with KOSA.

Advocates think something more nefarious is at play.

“The influence of these platforms is really powerful, and they want to stop this legislation and any other tech legislation by any means necessary,” said Alix Fraser of Issue One, a nonpartisan nonprofit that researches money in politics.

Meta spent nearly $19 million in the first nine months of 2024 lobbying Congress, some of it opposing KOSA.

KOSA timeline: The bill was introduced in 2022 after Facebook whistleblower Frances Haugen’s Senate testimony that Meta knew its products were harming users’ mental health. But the bill never reached a floor vote. In February, a new version of the bill aimed at protecting young people’s ability to access information online garnered a swell of support.

Five months later, the Senate passed the bill in a bipartisan 91-3 vote.

The surgeon general and attorneys general in 35 states, as well as doctors groups, including the American Academy of Pediatrics and the American Psychological Association, have all called on Congress to pass KOSA.

At the time, Johnson said he thought the bill would likely have support in the House. “The internet is the wild, wild West, and some of these reforms are overdue,” he told CNBC.

But the bill barely made it out of committee. In September, the House Energy and Commerce Committee advanced a weak version of the bill by voice vote, which members seemed unhappy with. Even with these changes, which were meant to address free speech concerns, Johnson didn’t bring it to the floor for a vote.

What’s next: Johnson has promised to address kids’ online safety in the new term. But parents and the bill’s advocates say, while lawmakers wait, more children are at risk.

"By failing to include the Kids Online Safety Act in the continuing resolution, the leadership of the House has failed the children of the United States,” said Josh Golin, executive director of children’s advocacy group Fairplay, noting that Johnson refused to meet with parents.

“It would have passed the House easily if it had been given a vote,” he said.

 

You read POLITICO for trusted reporting. Now follow every twist of the lame duck session with Inside Congress. We track the committee meetings, hallway conversations, and leadership signals that show where crucial year-end deals are heading. Subscribe now.

 
 
WELCOME TO FUTURE PULSE

A picture of a miniature Capitol building.

Washington, D.C. | Erin Schumaker / POLITICO

This is where we explore the ideas and innovators shaping health care.

Private bunker sales are on the rise amid global insecurity and fear of nuclear threats, the Associated Press reports.

Share any thoughts, news, tips and feedback with Carmen Paun at cpaun@politico.com, Daniel Payne at dpayne@politico.com, Ruth Reader at rreader@politico.com, or Erin Schumaker at eschumaker@politico.com.

Send tips securely through SecureDrop, Signal, Telegram or WhatsApp.

THE REGULATORS

Jay Obernolte speaks at POLITICO’s 2024 AI and Tech Summit.

Rep. Jay Obernolte (R-Calif.) co-chairs the House Task Force on Artificial Intelligence, which is concerned about AI-powered health care tools. | Rod Lamkey Jr. for POLITICO

The Food and Drug Administration might need enhanced oversight capability to effectively monitor artificial intelligence in health care, Ruth reports.

That’s according to a report from the bipartisan House Task Force on Artificial Intelligence, co-chaired by two California representatives, Republican Jay Obernolte and Democrat Ted Lieu, which lays out some of the biggest concerns about the AI-powered tools flooding into health care. Chief among them: privacy risks, potential for biased care delivery and lack of transparency about how the tools work.

Speaker Johnson and Minority Leader Hakeem Jeffries launched the task force in February, asking it to consider how to ensure the U.S. leads on innovation while considering guardrails.

Why it matters: Regulators are grappling with ways to monitor new AI tools in health care because their performance can deteriorate over time and vary significantly across different settings — such as rural and urban hospitals.

FDA head Robert Califf has said he would need to double his staff to properly vet the tools.

As a result, federal regulators, concerned about stifling innovation, have hesitated to implement new rules to govern AI. At the same time, health systems say regulation to ensure safety would improve their confidence in adopting it.

What’s next? Regulators and the health care industry are waiting to see where President-elect Donald Trump comes down on AI regulation.

Trump has pledged to rescind President Joe Biden’s 2023 executive order on AI, which tasked agencies with developing safety measures. Trump’s campaign platform derided “Radical Leftwing ideas on the development of this technology” while promising “AI Development rooted in Free Speech and Human Flourishing."

On the other hand, Trump takes advice from billionaire AI pioneer Elon Musk, who is co-leading the "Department of Government Efficiency," an initiative that will recommend budget cuts to the Trump administration. Musk sees the technology’s potential for harm and backed a California bill to regulate it earlier this year. If Musk has clout, Trump could prefer stricter government oversight.

 

POLITICO Pro's unique analysis combines exclusive transition intelligence and data visualization to help you understand not just what's changing, but why it matters for your organization. Explore how POLITICO Pro will make a difference for you.

 
 
WORLD VIEW

A man leaves the logistics hub of French association "Medecins sans frontieres" (Doctors without borders) on January 13, 2010 in Bordeaux-Merignac, as the association gets ready to provide medicines in Haiti following a huge earthquake there. The strongest earthquake to hit Haiti in over a century rocked the impoverished Caribbean nation, toppling buildings and triggering fears that hundreds have been killed in a wave of   destruction. AFP PHOTO PIERRE ANDRIEU (Photo by PIERRE ANDRIEU / AFP) (Photo by PIERRE ANDRIEU-/AFP via Getty Images)

Doctors Without Borders campaigns to lower drug prices included successful efforts to drive down HIV and hepatitis C treatment costs. Pierre Andrieu | AFP via Getty Images

Doctors Without Borders is ending one of its most high-profile and successful campaigns against high drug prices.

Following funding cuts, the rise of far-right governments and shrinking global and public health investment, the group is axing “Access Campaign,” a research unit, lobbying firm and protest campaign rolled into one, POLITICO EU's Rory O'Neill reports.

View from above: Doctors Without Borders says the campaign had become an “institution within an institution” that was increasingly unmoored from the group's frontline humanitarian work.

Although Doctors Without Borders eliminated the unit during an organizational restructuring, the group will continue some drug pricing work, it said.

Why it matters: Previous Access Campaign targets include successful efforts to drive down the price of HIV drugs, hepatitis C treatments and bedaquiline, a key treatment for drug-resistant tuberculosis.

Critics worry that losing one of the pharmaceutical industry's strongest adversaries, which worked to lower drug prices for 25 years, is a gift to drug companies.

Doctors Without Borders International President Christos Christou said the pharmaceutical industry shouldn't celebrate prematurely: “If they opened that Champagne, they will regret that.”

 

Follow us on Twitter

Carmen Paun @carmenpaun

Daniel Payne @_daniel_payne

Ruth Reader @RuthReader

Erin Schumaker @erinlschumaker

 

Follow us

Follow us on Facebook Follow us on Twitter Follow us on Instagram Listen on Apple Podcast
 

To change your alert settings, please log in at https://login.politico.com/?redirect=https%3A%2F%2Fwww.politico.com/settings

This email was sent to edwardlorilla1986.paxforex@blogger.com by: POLITICO, LLC 1000 Wilson Blvd. Arlington, VA, 22209, USA

Unsubscribe | Privacy Policy | Terms of Service

No comments:

Post a Comment